Showing results (21-30 of 59) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Phase I and pharmacokinetic study of sequential paclitaxel and trabectedin every 2 weeks in patients with advanced solid tumorsQuincy Chu, Alain Mita, Bahram Forouzesh, et al.Clinical Nutrition ESPEN|November 13, 2020
Plasma levels of platinum-induced fatty acid [16:4n-3] do not affect response to platinum-based chemotherapy: A pilot study in non-small cell lung cancer patientsBarbara S van der Meij, Laisa Teleni, Avalyn E Stanislaus, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignanciesBahram Forouzesh, Manuel Hidalgo, Quincy Chu, et al.International Journal of Cancer|June 20, 2024
Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancerBarbara Melosky, Mark D Vincent, Anna L McGuire, et al.Clinical Lung Cancer|June 24, 2015
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung CancerPeter M Ellis, Natasha B Leighl, Vera Hirsh, et al.The Oncologist|August 30, 2020
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung CancerBarbara Melosky, Parneet K Cheema, Anthony Brade, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 15, 2018
Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trialsSeyyed Mohammad Reza Kazemi-Bajestani, Harald Becher, Charles Butts, et al.American Journal of Clinical Oncology|April 7, 2020
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid TumorsPaul C McDonald, Stephen Chia, Philippe L Bedard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignanciesEric K Rowinsky, Muralidhar Beeram, Lisa A Hammond, et al.Therapeutic Advances in Medical Oncology|November 22, 2021
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancerBarbara Melosky, Parneet Cheema, Rosalyn A Juergens, et al.Pageof 6